Dennis Matheis bought $100k of DRIO
director at DarioHealth Corp.. 14,430 shares at an average of $6.93, traded Jul 23, 2026, filed Jul 28, 2026.
Score components
- +15RoleDirector
- +10Trade size$100k at market
- +10Relative to holdingsHoldings up 50%
- +8Price context57% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- -5Track recordMedian 6-month excess return -36% over 3 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-087626, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 12, 2024 | CConversion Common Stock | +965 | $19.10 | $18k | 28,596 | Jul 28, 2026 |
| Jul 23, 2026 | POpen-market purchase Common Stock | +14,430 | $6.93 | $100k | 43,026 | Jul 28, 2026 |
| Aug 12, 2024 | CConversion Series B-2 Preferred Stockderivative | -50 | $1,000.00 | $50k | 0 | Jul 28, 2026 |
Related signals
Other insiders at DarioHealth Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | DRIObuy DarioHealth Corp. | Steven Charles Nelson President and CCO | $21k 40,000 shares | +73% | |
| 18Weak | DRIObuy DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $4,546 5,000 shares | +10% | |
| 52Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $8,244 10,000 shares | +25% | |
| 56Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $12k 15,000 shares | +60% | |
| 51Moderate | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $4,400 5,000 shares | +0% | |
| 41Moderate | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $9,400 10,000 shares | +1% | |
| 46Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $14k 15,000 shares | +150% | |
| 36Weak | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $8,980 10,000 shares | +1% | |
| 39Weak | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $9,283 10,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.